1 |
孟琴琴, 郭美亮, 袁定芬, 等. SGK1功能的研究进展及临床意义[J]. 医学综述, 2020, 26(3): 427-432.
|
2 |
MAIYAR A C, LEONG M L L, FIRESTONE G L. Importin-alpha mediates the regulated nuclear targeting of serum- and glucocorticoid-inducible protein kinase (Sgk) by recognition of a nuclear localization signal in the kinase central domain[J].Mol Biol Cell, 2003,14(3): 1221-1239.
|
3 |
VASUDEVAN K M, BARBIE D A, DAVIES M A, et al. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer[J]. Cancer Cell, 2009, 16(1): 21-32.
|
4 |
CHIBA K. Oocyte maturation in starfish[J]. Cells, 2020, 9(2): 476.
|
5 |
BASNET R, GONG G Q, LI C Y, et al. Serum and glucocorticoid inducible protein kinases (SGKs): a potential target for cancer intervention[J]. Acta Pharm Sin B, 2018, 8(5): 767-771.
|
6 |
CHEN Y, SUN Z Y, QI M, et al. INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway[J]. J Cell Mol Med, 2018, 22(5): 2935-2943.
|
7 |
TESSIER M, WOODGETT J R. Role of the Phox homology domain and phosphorylation in activation of serum and glucocorticoid-regulated kinase-3[J]. J Biol Chem, 2006, 281(33): 23978-23989.
|
8 |
ANDJELKOVIĆ M, ALESSI D R, MEIER R, et al. Role of translocation in the activation and function of protein kinase B[J]. J Biol Chem, 1997, 272(50): 31515-31524.
|
9 |
TOSON B, FORTES I S, ROESLER R, et al. Targeting Akt/PKB in pediatric tumors: a review from preclinical to clinical trials[J]. Pharmacol Res, 2022, 183: 106403.
|
10 |
DONG Q Q, LI Z F, ZHANG H, et al. Serum and glucocorticoid-inducible kinase 3/Nedd4-2 signaling pathway participates in podocyte injury by regulating the stability of nephrin[J]. Front Physiol, 2022, 12: 810473.
|
11 |
LIAO Q Q, DONG Q Q, ZHANG H, et al. Contributions of SGK3 to transporter-related diseases[J]. Front Cell Dev Biol, 2022, 10: 1007924.
|
12 |
LANG F, COHEN P. Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms[J]. Sci STKE, 2001, 2001(108): re17.
|
13 |
NTOSTIS P, ILES D, KOKKALI G, et al. The impact of maternal age on gene expression during the GV to MⅡ transition in euploid human oocytes[J]. Hum Reprod, 2021, 37(1): 80-92.
|
14 |
YOON S Y. Role of type 1 inositol 1, 4, 5-triphosphate receptors in mammalian oocytes[J]. Dev Reprod, 2019, 23(1): 1-9.
|
15 |
QI L B, LIU B X, CHEN X, et al. Single-cell transcriptomic analysis reveals mitochondrial dynamics in oocytes of patients with polycystic ovary syndrome[J]. Front Genet, 2020, 11: 396.
|
16 |
AHMED M, FEZAI M, UZCATEGUI N L, et al. SGK3 sensitivity of voltage gated K+ channel Kv1.5 (KCNA5)[J]. Cell Physiol Biochem, 2016, 38(1): 359-367.
|
17 |
LANG F, BÖHMER C, PALMADA M, et al. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms[J]. Physiol Rev, 2006, 86(4): 1151-1178.
|
18 |
HIRAOKA D, HOSODA E, CHIBA K, et al. SGK phosphorylates Cdc25 and Myt1 to trigger cyclin B-Cdk1 activation at the meiotic G2/M transition[J]. J Cell Biol, 2019, 218(11): 3597-3611.
|
19 |
JU C, ZHOU R H, SUN J, et al. LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axis[J]. Cancer Cell Int, 2018, 18: 141.
|
20 |
FAN X R, ZHANG Z Y, WANG R H, et al. miR-376a functions as tumor suppressor by targeting SGK3 in renal cell carcinoma[J]. Eur Rev Med Pharmacol Sci, 2019, 23(9): 3726-3732.
|
21 |
ZHENG H Z, WU L P, WANG X D, et al. Risk of nasopharyngeal carcinoma associated with single nucleotide polymorphisms in the microRNA binding site of SGK3[J]. Genet Test Mol Biomarkers,2020,24(8): 508-519.
|